Chapters

Transcript

Video

So that our learners can better understand your experience and expertise in cancer immunotherapy and clinical trial design, can you share your current role and affiliations and how you became involved in the phase 1 nemvaleukin trial ARTISTRY-1?


Created by

CMEducation Resources | iQ&A Cytokine Immunotherapy Intelligence Zone

Presenter

Ulka Vaishampayan, MBBS

Ulka Vaishampayan, MBBS

Professor of Internal MedicineDirector, Phase I ProgramRogel Cancer CenterUniversity of MichiganAnn Arbor, MI